IQV · Iqvia Holdings Inc.
$236.66
-4.86 (-2.01%)
At close · Aug 14
Market Cap
$40.31B
Shares
166.90M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| William G. Kaelin Jr. | Board of Directors | Appointed | 2025-11-05 |
| Ronald E. Bruehlman | Senior Advisor to the CEO | Appointed | 2025-09-02 |
| Ronald E. Bruehlman | Executive Vice President and Chief Financial Officer | Retired | 2025-09-02 |
| Michael J. Fedock | Executive Vice President and Chief Financial Officer | Appointed | 2025-09-02 |
| Richard Staub III | President of its Research & Development Solutions ("R&DS") business unit | Appointed | 2023-09-26 |
| Ronald A. Rittenmeyer | member of the board of directors | Resigned | 2022-10-03 |
| Ronald A. Rittenmeyer | chairman of the Leadership Development and Compensation Committee ("LDCC") of the Company | Resigned | 2022-10-03 |
| Keriann Cherofsky | Senior Vice President, Corporate Controller (Principal Accounting Officer) | Appointed | 2022-07-29 |
Key facts
CIK
1478242
CUSIP
46266C105
13F (30d)
1009 filings
977 filers
Visit website
Investor relations